Payr Stephan, Dangl Theresia, Schuller Andrea, Scheider Philipp, Chocholka Britta, Jaindl Manuela, Schwendenwein Elisabeth, Tiefenboeck Thomas M
Department of Orthopedics and Trauma Surgery, Division of Trauma Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Children (Basel). 2022 Jan 31;9(2):172. doi: 10.3390/children9020172.
The COVID-19 pandemic and the resulting restrictions led to a reduced number of surgeries. This study examines its impact on the course of treatment and clinical outcome of surgically treated paediatric upper limb fractures during that specific period. This retrospective cohort study evaluated all children aged 0-18 years presenting with an upper limb fracture treated surgically at the level 1 trauma centre of the University Clinic of Orthopaedics and Trauma Surgery of Vienna within lockdown from 16 March to 29 May 2020 (definition applied through corresponding legislation) compared to the same period from 2015 to 2019. A total number of 127 children (m:63; f:44) were included. The lockdown did not lead to a significant increase in complications during and after initial surgery. Time until removal of implant was not significantly prolonged ( = 0.068; = 0.46). The clinical outcome did not significantly differ compared to previous years. The experience of a level 1 trauma centre showed that despite reduced surgical capacity during the COVID-19 pandemic, no negative differences concerning course of treatment and clinical outcome of surgically treated paediatric upper limb fractures were present. These findings are still of importance since the COVID-19 pandemic continues and several countries in Central Europe are currently under their fourth lockdown.
新冠疫情及其导致的限制措施致使手术数量减少。本研究考察了在此特定时期,其对接受手术治疗的小儿上肢骨折治疗过程及临床结果的影响。这项回顾性队列研究评估了2020年3月16日至5月29日封锁期间(根据相应立法适用的定义),在维也纳大学矫形与创伤外科一级创伤中心接受上肢骨折手术治疗的所有0至18岁儿童,并与2015年至2019年同期进行比较。总共纳入了127名儿童(男63名;女44名)。封锁并未导致初次手术期间及术后并发症显著增加。植入物取出前的时间未显著延长( = 0.068; = 0.46)。与前几年相比,临床结果无显著差异。一级创伤中心的经验表明,尽管在新冠疫情期间手术能力下降,但在接受手术治疗的小儿上肢骨折的治疗过程和临床结果方面,并未出现负面差异。鉴于新冠疫情仍在持续,且中欧几个国家目前正处于第四次封锁之下,这些研究结果仍然具有重要意义。